ASO作者反思：多发性肝细胞癌的肝切除术 - Suppr | 超能文献

ASO Author Reflections: Hepatectomy for Multiple Hepatocellular Carcinomas.

作者信息

Orimo Tatsuya, Kamiyama Toshiya, Taketomi Akinobu

机构信息

Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

Ann Surg Oncol. 2022 Dec;29(13):8446-8447. doi: 10.1245/s10434-022-12507-y. Epub 2022 Sep 5.

DOI:10.1245/s10434-022-12507-y

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

ASO Author Reflections: Hepatectomy for Multiple Hepatocellular Carcinomas.ASO作者反思：多发性肝细胞癌的肝切除术

Ann Surg Oncol. 2022 Dec;29(13):8446-8447. doi: 10.1245/s10434-022-12507-y. Epub 2022 Sep 5.

2

ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation.ASO作者反思：肝细胞癌患者肝移植前的移植前治疗

Ann Surg Oncol. 2023 Mar;30(3):1420-1421. doi: 10.1245/s10434-022-12964-5. Epub 2023 Jan 13.

3

ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.ASO作者反思：术前高凝状态预示肝切除术后微血管侵犯的肝细胞癌患者预后不良。

Ann Surg Oncol. 2019 Dec;26(Suppl 3):806-807. doi: 10.1245/s10434-019-07986-5. Epub 2019 Oct 25.

4

ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?ASO作者反思：超出BCLC指南的肝细胞癌切除术——机器学习技术如何提供帮助？

Ann Surg Oncol. 2020 Mar;27(3):875-876. doi: 10.1245/s10434-019-08036-w. Epub 2019 Nov 4.

5

ASO Author Reflections: The Prognostic Value of Preoperative Serum Markers and Risk Classification of Patients With Hepatocellular Carcinoma.ASO作者反思：术前血清标志物对肝细胞癌患者的预后价值及风险分类

Ann Surg Oncol. 2023 May;30(5):2816-2817. doi: 10.1245/s10434-022-13063-1. Epub 2023 Feb 3.

6

ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?ASO作者反思：转化治疗后不可切除肝细胞癌挽救性手术的影响：是否应推荐？

Ann Surg Oncol. 2024 May;31(5):3100-3101. doi: 10.1245/s10434-024-14991-w. Epub 2024 Feb 1.

7

ASO Author Reflections: An Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Patients with Hepatocellular Carcinoma.ASO作者反思：一种用于预测肝细胞癌患者术前微血管侵犯风险的在线计算器。

Ann Surg Oncol. 2023 Feb;30(2):734-735. doi: 10.1245/s10434-022-12498-w. Epub 2022 Sep 4.

8

ASO Author Reflections: TBS-Based Preoperative Score to Predict Non-Transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.ASO作者反思：基于TBS的术前评分预测不可移植性复发并确定肝细胞癌直接切除与移植候选者。

Ann Surg Oncol. 2023 Jun;30(6):3374-3375. doi: 10.1245/s10434-023-13304-x. Epub 2023 Mar 24.

9

ASO Author Reflections: Identifying Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.ASO作者反思：确定伴有门静脉癌栓的肝细胞癌的最佳手术候选者

Ann Surg Oncol. 2019 Dec;26(Suppl 3):551-552. doi: 10.1245/s10434-018-7018-0. Epub 2018 Dec 18.

10

ASO Author Reflections: Recurrence Patterns and Outcomes After Resection of Hepatocellular Carcinoma Within and Beyond the Barcelona Clinic Liver Cancer Criteria.ASO作者反思：巴塞罗那临床肝癌标准范围内外肝细胞癌切除术后的复发模式与结局

Ann Surg Oncol. 2020 Jul;27(7):2332-2333. doi: 10.1245/s10434-020-08455-0. Epub 2020 Apr 15.

本文引用的文献

1

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.肝细胞癌的试验设计与终点：美国肝病研究学会共识会议

Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9.

2

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.肝细胞癌临床实践指南：日本肝脏学会2017年（第4版日本肝脏学会肝细胞癌指南）2019年更新版

Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6.